Erlanger Health announces the recent completion of surgeries using new Pulsed Field Ablation (PFA) technology to better treat patients battling atrial fibrillation (AFib). Officials said, "As the ...

EMPAVELI's key market opportunities include its strong differentiation through C3 inhibition, capturing PNH patients inadequately controlled by C5 inhibitors. Expansion into rare kidney diseases, ...

Check approved for trading on Nasdaq First North - Regulatory This Press Release should not be released or distributed, directly or indirectly, within USA, Canada, Japan, Australia ...

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced the submission of ...

Detailed results from RISE UP Phase 3 trial of mitapivat in sickle cell disease selected for distinguished Plenary Abstracts Session; Company to host investor conference call and ...

Presented positive clinical data for pociredir, demonstrating robust and rapid fetal hemoglobin (HbF) induction, improvements in markers of hemolysis and anemia, and encouraging trends in vaso-occlusi ...

Presented positive clinical data for pociredir, demonstrating robust and rapid fetal hemoglobin (HbF) induction, improvements in markers of ...

A new, fast and easy test could revolutionize blood transfusions—giving blood centers and hospitals a reliable way to monitor the quality of red blood cells after they sit for weeks in storage. The ...

A Japanese center found that hemolysis was significantly more common after TAVR with the Sapien 3 Ultra Resilia than with its predecessor device, despite the improvement on paravalvular leaks. Annular ...

Hemolysis is a recognized side effect of pulsed field ablation (PFA). Severe hemolysis can lead to acute kidney injury, affecting the morbidity of patients undergoing PFA for atrial fibrillation. Here ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Nuwellis ( (NUWE)) has shared an update.